How we think - Archive
September 2015

Here are all the posts from the How we think section that were published in September 2015. If you don’t see the post you’re looking for here, try our search feature or looking in the tags index.

These archives are only from the How we think section, if you’re looking for the archive for our company news page, click here.

patient-centricity-elisa-del-galdo-blue-latitude-health

Patient-centricity: Navigating away from the centre

Elisa del Galdo|15th September 2015

Traditionally, we look at the environment of the patient with the patient in the centre of a circle of healthcare professionals, carers, institutions or clinics, and sometimes services. Elisa del Galdo takes us through a better way to look at patient-centricity: with the patient’s journey at the centre.

read more

clinic-medical-scientist-medicine-lab

Tackling biosimilars – how to handle the threat to pharma brands

Mark Assenti|23rd September 2015

Recently, Blue Latitude Health worked with a global pharmaceutical brand to develop a strategy for dealing with the introduction of biosimilars to the market. Their product, a treatment in the gastroenterology therapy area, had recently come off patent and a biosimilar was about to launch. Strategy Consultant Mark Assenti talks through three key points for developing a strategy to tackle biosimilars.

read more

sketchnote-blue-latitude-health-portfolio-planning

Bigger than brand: Portfolio positioning for pharma

Jenna Earl|29th September 2015

With pharma in the midst of a patent cliff, portfolios of treatments are becoming more and more common, and the need for a clear co-positioning strategy has never been greater.

Head of Brand Strategy Jenna Earl talks us through the three most important things to understand about portfolio positioning in pharma.

read more